The Pre-POINT study , a double-blind , placebo-controlled , dose-escalation , phase @/@ clinical pilot study performed between @ and @ in Germany , Austria , the United States , and the United Kingdom and enrolling @ islet autoantibody-negative children aged @ to @ years with a family history of type @ diabetes and susceptible human leukocyte antigen class II genotypes .